Replies to post #191142 on Vivos Inc (RDGL)

[rogers711]

I'm pretty sure they stated all patients met the safety endpoints, I think regardless of early efficacy data, if they have proven it safe in humans, they should be allowed to prove it's safe to the fda as well through a repeat trial... 

[pumper_stumper]

It's not puzzling at all, and in fact should tell people all they need to know about this.

The company leaving us in the dark about the results thus far, other than the one interview, is a little bit puzzling to me.

But with the "expertise" of those that "invest" in OTC stocks, it surely will be lost on them, and just as likely, be viewed somehow as a positive!